Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view
The Pharmacogenomics Journal, Published online: 02 December 2019; doi:10.1038/s41397-019-0123-zPharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - December 1, 2019 Category: Drugs & Pharmacology Authors: Reka Varnai Istvan Szabo Greta Tarlos Laszlo Jozsef Szentpeteri Attila Sik Sandor Balogh Csilla Sipeky Source Type: research
Ketamine in seizure management and future pharmacogenomic considerations
The Pharmacogenomics Journal, Published online: 27 November 2019; doi:10.1038/s41397-019-0120-2Ketamine in seizure management and future pharmacogenomic considerations (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 26, 2019 Category: Drugs & Pharmacology Authors: Giovanna Soldatelli Borsato Jason L. Siegel Mariah Q. Rose Michelle Ojard Anteneh Feyissa Alfredo Quinones-Hinojosa Daniel A. Jackson Emily R. Rogers William D. Freeman Source Type: research
Gender based differences, pharmacogenetics and adverse events in chronic pain management
The Pharmacogenomics Journal, Published online: 20 November 2019; doi:10.1038/s41397-019-0118-9Gender based differences, pharmacogenetics and adverse events in chronic pain management (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - November 19, 2019 Category: Drugs & Pharmacology Authors: Beatriz Planelles C ésar Margarit Mar ía-del-Mar Inda Pura Ballester Javier Muriel Jordi Barrachina Raquel Ajo Mar ía-Dolores Esteban Ana M Peir ó Source Type: research
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis
The Pharmacogenomics Journal, Published online: 01 November 2019; doi:10.1038/s41397-019-0117-xCYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 31, 2019 Category: Drugs & Pharmacology Authors: Masanobu Takeuchi Tohru Kobayashi Tina Biss Farhad Kamali Susan I. Vear Richard H. Ho Fanny Bajolle Marie-Anne Loriot Kaitlyn Shaw Bruce C. Carleton Anna-Karin Hamberg Mia Wadelius Keiichi Hirono Masato Taguchi Takuya Wakamiya Masakatsu Yanagimachi Keita Source Type: research
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study
The Pharmacogenomics Journal, Published online: 31 October 2019; doi:10.1038/s41397-019-0113-1Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 30, 2019 Category: Drugs & Pharmacology Authors: Eva Clemens Linda Broer Thorsten Langer Andr é G. Uitterlinden Andrica C. H. de Vries Martine van Grotel Saskia F. M. Pluijm Harald Binder Julianne Byrne Eline van Dulmen-den Broeder Marco Crocco Desiree Grabow Peter Kaatsch Melanie Kaiser Line Kenborg J Source Type: research
Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients
The Pharmacogenomics Journal, Published online: 30 October 2019; doi:10.1038/s41397-019-0115-zPolymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 29, 2019 Category: Drugs & Pharmacology Authors: Shuang Xin Yuanyuan Zhao Changzheng Wang Yan Huang Wei Zhuang Yuxiang Ma Min Huang Xun Xu Xueding Wang Li Zhang Source Type: research
The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population
The Pharmacogenomics Journal, Published online: 25 October 2019; doi:10.1038/s41397-019-0116-yThe effect of genetic and nongenetic factors on warfarin dose variability in Qatari population (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 24, 2019 Category: Drugs & Pharmacology Authors: Loulia Bader Ahmad Mahfouz Mohammed Kasem Shaban Mohammed Sumayya Alsaadi Osama Abdelsamad Rasha Elenani Ezeldin Soaly Abdelnasser Elzouki Nasser Rizk Sherief Khalifa Mohamed H. Shahin Larisa H. Cavallari Fatima Mraiche Hazem Elewa Source Type: research
The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker
The Pharmacogenomics Journal, Published online: 24 October 2019; doi:10.1038/s41397-019-0114-0The efficacy of interferon-beta therapy in multiple sclerosis patients: investigation of the RORA gene as a predictive biomarker (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 23, 2019 Category: Drugs & Pharmacology Authors: Seyed Abdulmajid Ayatollahi Soudeh Ghafouri-Fard Mohammad Taheri Rezvan Noroozi Source Type: research
A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs
The Pharmacogenomics Journal, Published online: 21 October 2019; doi:10.1038/s41397-019-0101-5A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 20, 2019 Category: Drugs & Pharmacology Authors: Akane Yoshikawa Jiang Li Herbert Y. Meltzer Source Type: research
Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults
The Pharmacogenomics Journal, Published online: 21 October 2019; doi:10.1038/s41397-019-0112-2Meta-analysis of the associations of CYP2B6-516G>T polymorphisms with efavirenz-induced central nervous system side effects and virological outcome in HIV-infected adults (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 20, 2019 Category: Drugs & Pharmacology Authors: Lin Cheng Yu Wang Xiaoyu Li Wei Feng Bangbi Weng Qian Yuan Peiyuan Xia Fengjun Sun Source Type: research
Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers
The Pharmacogenomics Journal, Published online: 18 October 2019; doi:10.1038/s41397-019-0103-3Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 17, 2019 Category: Drugs & Pharmacology Authors: Pablo Zubiaur Miriam Saiz-Rodr íguez Dolores Ochoa Carmen Belmonte Manuel Rom án Gina Mej ía Samuel Mart ín-Vilchez Francisco Abad-Santos Source Type: research
Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure?
The Pharmacogenomics Journal, Published online: 17 October 2019; doi:10.1038/s41397-019-0111-3Pharmacogenetic interactions in amyotrophic lateral sclerosis: a step closer to a cure? (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 16, 2019 Category: Drugs & Pharmacology Authors: Ruben P. A. van Eijk Marinus J. C. Eijkemans Stavros Nikolakopoulos Marc D. Jansen Henk-Jan Westeneng Kristel R. van Eijk Rick A. A. van der Spek Joke J. F. A. van Vugt Sanne Piepers Geert-Jan Groeneveld Jan H. Veldink Leonard H. van den Berg Michael A. v Source Type: research
Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
The Pharmacogenomics Journal, Published online: 17 October 2019; doi:10.1038/s41397-019-0110-4Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 16, 2019 Category: Drugs & Pharmacology Authors: Qianqian Meng Shuyuan Wang Shunheng Zhou Haizhou Liu Xueyan Ma Xu Zhou Hui Liu Chaohan Xu Wei Jiang Source Type: research
ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide
The Pharmacogenomics Journal, Published online: 17 October 2019; doi:10.1038/s41397-019-0107-zABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 16, 2019 Category: Drugs & Pharmacology Authors: Annika Malmstr öm Malgorzata Łysiak Lisa Åkesson Ingrid Jakobsen Munila Mudaisi Peter Milos Martin Hallbeck Victoria Fomichov Helle Broholm Kirsten Grunnet Hans Skovgaard Poulsen Charlotte Bratth äll Michael Strandeus Angeliki Papagiannopoulou Marie S Source Type: research
Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review
The Pharmacogenomics Journal, Published online: 17 October 2019; doi:10.1038/s41397-019-0098-9Predictive genetic biomarkers for the efficacy of methotrexate in rheumatoid arthritis: a systematic review (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - October 16, 2019 Category: Drugs & Pharmacology Authors: Frank Eektimmerman Jesse J. Swen Moenira B. Madhar Cornelia F. Allaart Henk-Jan Guchelaar Source Type: research
